Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy.

Weber WP, Haug M, Kurzeder C, Bjelic-Radisic V, Koller R, Reitsamer R, Fitzal F, Biazus J, Brenelli F, Urban C, Paulinelli RR, Blohmer JU, Heil J, Hoffmann J, Matrai Z, Catanuto G, Galimberti V, Gentilini O, Barry M, Hadar T, Allweis TM, Olsha O, Cardoso MJ, Gouveia PF, Rubio IT, de Boniface J, Svensjö T, Bucher S, Dubsky P, Farhadi J, Fehr MK, Fulco I, Ganz-Blättler U, Günthert A, Harder Y, Hauser N, Kappos EA, Knauer M, Landin J, Mechera R, Meani F, Montagna G, Ritter M, Saccilotto R, Schwab FD, Steffens D, Tausch C, Zeindler J, Soysal SD, Lohsiriwat V, Kovacs T, Tansley A, Wyld L, Romics L, El-Tamer M, Pusic AL, Sacchini V, Gnant M.

Breast Cancer Res Treat. 2018 Dec;172(3):523-537. doi: 10.1007/s10549-018-4937-1. Epub 2018 Sep 4. Review.

PMID:
30182349
2.

Associations of Hospital Length of Stay with Surgical Site Infections.

Mujagic E, Marti WR, Coslovsky M, Soysal SD, Mechera R, von Strauss M, Zeindler J, Saxer F, Mueller A, Fux CA, Kindler C, Gurke L, Weber WP.

World J Surg. 2018 Dec;42(12):3888-3896. doi: 10.1007/s00268-018-4733-4.

PMID:
29978247
3.

Impact of a Surgical Sealing Patch on Lymphatic Drainage After Axillary Dissection for Breast Cancer: The SAKK 23/13 Multicenter Randomized Phase III Trial.

Weber WP, Tausch C, Hayoz S, Fehr MK, Ribi K, Hawle H, Lupatsch JE, Matter-Walstra K, Chiesa F, Dedes KJ, Berclaz G, Lelièvre L, Hess T, Güth U, Pioch V, Sarlos D, Leo C, Canonica C, Gabriel N, Zeindler J, Cassoly E, Andrieu C, Soysal SD, Ruhstaller T, Fehr PM, Knauer M; Swiss Group for Clinical Cancer Research (SAKK).

Ann Surg Oncol. 2018 Sep;25(9):2632-2640. doi: 10.1245/s10434-018-6556-9. Epub 2018 Jun 8.

PMID:
29948418
4.

The association of surgical drains with surgical site infections - A prospective observational study.

Mujagic E, Zeindler J, Coslovsky M, Hoffmann H, Soysal SD, Mechera R, von Strauss M, Delko T, Saxer F, Glaab R, Kraus R, Mueller A, Curti G, Gurke L, Jakob M, Marti WR, Weber WP.

Am J Surg. 2018 Jun 19. pii: S0002-9610(18)30672-X. doi: 10.1016/j.amjsurg.2018.06.015. [Epub ahead of print]

PMID:
29935905
5.

High-resolution standardization reduces delay due to workflow disruptions in laparoscopic cholecystectomy.

von Strauss Und Torney M, Aghlmandi S, Zeindler J, Nowakowski D, Nebiker CA, Kettelhack C, Rosenthal R, Droeser RA, Soysal SD, Hoffmann H, Mechera R.

Surg Endosc. 2018 Dec;32(12):4763-4771. doi: 10.1007/s00464-018-6224-y. Epub 2018 May 21.

PMID:
29785458
6.

Die Rolle der onkoplastischen Chirurgie in der Behandlung des Mammakarzinoms.

Kappos EA, Weber WP, Soysal SD, Schwab F, Kurzeder C, Haug MD.

Praxis (Bern 1994). 2017;106(25):1378-1382. doi: 10.1024/1661-8157/a002852. German. No abstract available.

PMID:
29231082
7.

The role of preoperative blood parameters to predict the risk of surgical site infection.

Mujagic E, Marti WR, Coslovsky M, Zeindler J, Staubli S, Marti R, Mechera R, Soysal SD, Gürke L, Weber WP.

Am J Surg. 2018 Apr;215(4):651-657. doi: 10.1016/j.amjsurg.2017.08.021. Epub 2017 Sep 14.

PMID:
28982517
8.

Phosphorylated CXCR4 expression has a positive prognostic impact in colorectal cancer.

Weixler B, Renetseder F, Facile I, Tosti N, Cremonesi E, Tampakis A, Delko T, Eppenberger-Castori S, Tzankov A, Iezzi G, Kettelhack C, Soysal SD, von Holzen U, Spagnoli GC, Terracciano L, Tornillo L, Droeser RA, Däster S.

Cell Oncol (Dordr). 2017 Dec;40(6):609-619. doi: 10.1007/s13402-017-0348-2. Epub 2017 Sep 21.

PMID:
28936810
9.

Ex-vivo assessment of drug response on breast cancer primary tissue with preserved microenvironments.

Muraro MG, Muenst S, Mele V, Quagliata L, Iezzi G, Tzankov A, Weber WP, Spagnoli GC, Soysal SD.

Oncoimmunology. 2017 May 30;6(7):e1331798. doi: 10.1080/2162402X.2017.1331798. eCollection 2017.

10.

Current standards in oncoplastic breast conserving surgery.

Weber WP, Soysal SD, Zeindler J, Kappos EA, Babst D, Schwab F, Kurzeder C, Haug M.

Breast. 2017 Aug;34 Suppl 1:S78-S81. doi: 10.1016/j.breast.2017.06.033. Epub 2017 Jul 6.

PMID:
28690106
11.

Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity.

Zhang X, Kim S, Hundal J, Herndon JM, Li S, Petti AA, Soysal SD, Li L, McLellan MD, Hoog J, Primeau T, Myers N, Vickery TL, Sturmoski M, Hagemann IS, Miller CA, Ellis MJ, Mardis ER, Hansen T, Fleming TP, Goedegebuure SP, Gillanders WE.

Cancer Immunol Res. 2017 Jul;5(7):516-523. doi: 10.1158/2326-6066.CIR-16-0264. Epub 2017 Jun 15.

12.

First international consensus conference on standardization of oncoplastic breast conserving surgery.

Weber WP, Soysal SD, El-Tamer M, Sacchini V, Knauer M, Tausch C, Hauser N, Günthert A, Harder Y, Kappos EA, Schwab F, Fitzal F, Dubsky P, Bjelic-Radisic V, Reitsamer R, Koller R, Heil J, Hahn M, Blohmer JU, Hoffmann J, Solbach C, Heitmann C, Gerber B, Haug M, Kurzeder C.

Breast Cancer Res Treat. 2017 Aug;165(1):139-149. doi: 10.1007/s10549-017-4314-5. Epub 2017 Jun 3.

PMID:
28578506
13.

Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue.

Muenst S, Mechera R, Däster S, Piscuoglio S, Ng CKY, Meier-Abt F, Weber WP, Soysal SD.

Oncotarget. 2017 Apr 4;8(14):22353-22360. doi: 10.18632/oncotarget.16023.

14.

Timing of surgical antimicrobial prophylaxis: a phase 3 randomised controlled trial.

Weber WP, Mujagic E, Zwahlen M, Bundi M, Hoffmann H, Soysal SD, Kraljević M, Delko T, von Strauss M, Iselin L, Da Silva RXS, Zeindler J, Rosenthal R, Misteli H, Kindler C, Müller P, Saccilotto R, Lugli AK, Kaufmann M, Gürke L, von Holzen U, Oertli D, Bucheli-Laffer E, Landin J, Widmer AF, Fux CA, Marti WR.

Lancet Infect Dis. 2017 Jun;17(6):605-614. doi: 10.1016/S1473-3099(17)30176-7. Epub 2017 Apr 3. Erratum in: Lancet Infect Dis. 2017 Dec;17 (12 ):1232.

PMID:
28385346
15.

Standardization of oncoplastic breast conserving surgery.

Weber WP, Soysal SD, Fulco I, Barandun M, Babst D, Kalbermatten D, Schaefer DJ, Oertli D, Kappos EA, Haug M.

Eur J Surg Oncol. 2017 Jul;43(7):1236-1243. doi: 10.1016/j.ejso.2017.01.006. Epub 2017 Jan 31. Review.

PMID:
28214053
16.

Perioperative outcomes of esophageal cancer surgery in a mid-volume institution in the era of centralization.

Däster S, Soysal SD, Koechlin L, Stoll L, Peterli R, von Flüe M, Ackermann C.

Langenbecks Arch Surg. 2016 Sep;401(6):787-95. doi: 10.1007/s00423-016-1477-1. Epub 2016 Jul 19.

PMID:
27436366
17.

The immune system and cancer evasion strategies: therapeutic concepts.

Muenst S, Läubli H, Soysal SD, Zippelius A, Tzankov A, Hoeller S.

J Intern Med. 2016 Jun;279(6):541-62. doi: 10.1111/joim.12470. Epub 2016 Jan 8. Review.

18.

Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis.

Däster S, Eppenberger-Castori S, Hirt C, Soysal SD, Delko T, Nebiker CA, Weixler B, Amicarella F, Iezzi G, Governa V, Padovan E, Mele V, Sconocchia G, Heberer M, Terracciano L, Kettelhack C, Oertli D, Spagnoli GC, von Holzen U, Tornillo L, Droeser RA.

Oncoimmunology. 2015 May 29;4(12):e1050574. eCollection 2015 Dec.

19.

OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.

Weixler B, Cremonesi E, Sorge R, Muraro MG, Delko T, Nebiker CA, Däster S, Governa V, Amicarella F, Soysal SD, Kettelhack C, von Holzen UW, Eppenberger-Castori S, Spagnoli GC, Oertli D, Iezzi G, Terracciano L, Tornillo L, Sconocchia G, Droeser RA.

Oncotarget. 2015 Nov 10;6(35):37588-99. doi: 10.18632/oncotarget.5940.

20.

Role of the Tumor Microenvironment in Breast Cancer.

Soysal SD, Tzankov A, Muenst SE.

Pathobiology. 2015 Sep;82(3-4):142-52. doi: 10.1159/000430499. Epub 2015 Aug 31. Review.

21.

Status of estrogen receptor 1 (ESR1) gene in mastopathy predicts subsequent development of breast cancer.

Soysal SD, Kilic IB, Regenbrecht CR, Schneider S, Muenst S, Kilic N, Güth U, Dietel M, Terracciano LM, Kilic E.

Breast Cancer Res Treat. 2015 Jun;151(3):709-15. doi: 10.1007/s10549-015-3427-y. Epub 2015 May 16.

PMID:
25981900
22.

High frequency of CD8 positive lymphocyte infiltration correlates with lack of lymph node involvement in early rectal cancer.

Däster S, Eppenberger-Castori S, Hirt C, Zlobec I, Delko T, Nebiker CA, Soysal SD, Amicarella F, Iezzi G, Sconocchia G, Heberer M, Lugli A, Spagnoli GC, Kettelhack C, Terracciano L, Oertli D, von Holzen U, Tornillo L, Droeser RA.

Dis Markers. 2014;2014:792183. doi: 10.1155/2014/792183. Epub 2014 Dec 30.

23.

The PD-1/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy.

Muenst S, Soysal SD, Tzankov A, Hoeller S.

Expert Opin Ther Targets. 2015 Feb;19(2):201-11. doi: 10.1517/14728222.2014.980235. Epub 2014 Dec 10. Review.

PMID:
25491730
24.

Identification and translational validation of novel mammaglobin-A CD8 T cell epitopes.

Soysal SD, Muenst S, Kan-Mitchell J, Huarte E, Zhang X, Wilkinson-Ryan I, Fleming T, Tiriveedhi V, Mohanakumar T, Li L, Herndon J, Oertli D, Goedegebuure SP, Gillanders WE.

Breast Cancer Res Treat. 2014 Oct;147(3):527-37. doi: 10.1007/s10549-014-3129-x. Epub 2014 Sep 12.

25.

Author's response to "Letter to the editor: unvalidated antibodies and misleading results".

Muenst S, Tzankov A, Gillanders WE, Soysal SD.

Breast Cancer Res Treat. 2014 Sep;147(2):459-62. doi: 10.1007/s10549-014-3064-x. No abstract available.

PMID:
25082517
26.

Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer.

Muenst S, Schaerli AR, Gao F, Däster S, Trella E, Droeser RA, Muraro MG, Zajac P, Zanetti R, Gillanders WE, Weber WP, Soysal SD.

Breast Cancer Res Treat. 2014 Jul;146(1):15-24. doi: 10.1007/s10549-014-2988-5. Epub 2014 May 20.

27.

Long-term quality of life after Ivor Lewis esophagectomy for esophageal cancer.

Däster S, Soysal SD, Stoll L, Peterli R, von Flüe M, Ackermann C.

World J Surg. 2014 Sep;38(9):2345-51. doi: 10.1007/s00268-014-2576-1.

PMID:
24756548
28.

Nuclear expression of snail is an independent negative prognostic factor in human breast cancer.

Muenst S, Däster S, Obermann EC, Droeser RA, Weber WP, von Holzen U, Gao F, Viehl C, Oertli D, Soysal SD.

Dis Markers. 2013;35(5):337-44. doi: 10.1155/2013/902042. Epub 2013 Sep 22.

29.

The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer.

Muenst S, Soysal SD, Gao F, Obermann EC, Oertli D, Gillanders WE.

Breast Cancer Res Treat. 2013 Jun;139(3):667-76. doi: 10.1007/s10549-013-2581-3. Epub 2013 Jun 12.

30.

Src homology phosphotyrosyl phosphatase-2 expression is an independent negative prognostic factor in human breast cancer.

Muenst S, Obermann EC, Gao F, Oertli D, Viehl CT, Weber WP, Fleming T, Gillanders WE, Soysal SD.

Histopathology. 2013 Jul;63(1):74-82. doi: 10.1111/his.12140. Epub 2013 May 15.

31.

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer.

Soysal SD, Muenst S, Barbie T, Fleming T, Gao F, Spizzo G, Oertli D, Viehl CT, Obermann EC, Gillanders WE.

Br J Cancer. 2013 Apr 16;108(7):1480-7. doi: 10.1038/bjc.2013.80. Epub 2013 Mar 21.

32.

[Embolization of hydrophilic guide wire coating].

Muenst S, Willi N, Cathomas G, Jeger RV, Soysal SD, Glatz K.

Pathologe. 2012 Jul;33(4):345-7. doi: 10.1007/s00292-012-1588-6. German.

PMID:
22555363

Supplemental Content

Loading ...
Support Center